Evon Medics

Evon Medics is dedicated to researching and developing brain stimulation device prototypes and new drug ligands for the treatment of various neuropsychiatric disorders, including traumatic brain injury, post-traumatic stress disorder, treatment-resistant depression, obsessive-compulsive disorder, chronic pain, opioid addiction, and dementia. The company has a well-trained and diverse workforce, focusing on finding technological solutions for behaviors and neurological diseases that cause significant human suffering. We remain steadfastly committed to addressing the devastating impact of Alzheimer’s disease. In this pursuit, we are collaborating with other technology partners and global scientists to develop the first effective disease-modifying intervention for Alzheimer’s. We have also developed a brain stimulation paradigm for treating drug addiction. We hope that our products will embody our mission and commitment to promoting healthy brain function throughout the human lifespan in the coming years.